Cingulate Inc. Share Price
CINGCingulate Inc. Stock Performance
Open $4.90 | Prev. Close $5.00 | Circuit Range N/A |
Day Range $4.90 - $5.00 | Year Range $3.23 - $5.97 | Volume 801 |
Average Traded $4.92 |
Cingulate Inc. Share Price Chart
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-Jan-26 | $4.90 | $5.00 | +0.00% |
13-Jan-26 | $4.90 | $5.00 | +2.78% |
12-Jan-26 | $4.51 | $4.86 | +4.07% |
09-Jan-26 | $5.00 | $4.67 | -6.97% |
08-Jan-26 | $4.96 | $5.02 | +1.01% |
07-Jan-26 | $4.75 | $4.97 | +6.54% |
06-Jan-26 | $4.92 | $4.67 | -0.96% |
FAQs on Cingulate Inc. Share Price
Can I buy Cingulate Inc. shares in India?
What is the share price of Cingulate Inc.?
What is the 5 year returns of Cingulate Inc.?
What are the high & low stock price of Cingulate Inc. today?
What is the 52-week high and low of Cingulate Inc. stock?